What is Invictus MD?
Invictus MD is a global cannabis enterprise with a strategic focus on the Canadian market. The company offers a diverse portfolio of cannabis products, catering to both medical clients and retail consumers by providing a wide range of cannabinoid profiles. To meet escalating demand, Invictus is actively expanding its cultivation capacity through two primary cannabis production facilities licensed under the Cannabis Act. These facilities, including Acreage Phase I and Phase II, are in full production, with Acreage having received amendments to its license for Phase III expansion. Furthermore, AB Laboratories Inc., a 50% owned subsidiary, has completed its Phase II expansion and obtained its amended license. Invictus also operates through its wholly-owned subsidiary, 2015059 Alberta Ltd. (dba Leaf Wise), which facilitates connections between medical clients and physicians, directing them to Invictus' licensed producers. The company aims to allocate up to 50 percent of its production to the medical cannabis sector, driving sustainable long-term shareholder value.
How much funding has Invictus MD raised?
Invictus MD has raised a total of $12M across 1 funding round:
Private Equity
$12M
Private Equity (2016): $12M, investors not publicly disclosed
What's next for Invictus MD?
With the recent strategic investment and substantial total funding, Invictus MD is well-positioned to accelerate its growth trajectory. The company's expansion of cultivation footprint and licensing achievements indicate a strong commitment to scaling operations. Future strategic initiatives will likely involve further penetration into its five distribution pillars, potentially including international market development and enhanced product innovation. The focus on both medical and retail cannabis segments suggests a balanced approach to market capture, aiming to leverage diverse revenue streams. Continued investment in production capacity and subsidiary operations signals a robust strategy for meeting market demand and solidifying its position as a key player in the evolving cannabis industry.
See full Invictus MD company page
